The Board of Directors approved an amendment to the Amended and Restated Bylaws, effective immediately. The new Article 12 designates the Court of Chancery of the State of Delaware as the exclusive forum for derivative actions, suits asserting breach of fiduciary duty by directors or officers, and other specified proceedings. Additionally, federal district courts in the United States are designated as the exclusive forum for complaints arising under the Securities Act of 1933. Inovio Pharmaceuticals is a biotechnology company focused on developing DNA-based therapeutic vaccines.
